Harpoon Therapeutics Inc (HARP)

Harpoon Therapeutics Financial Statements


Harpoon Therapeutics Financial Overview

Harpoon Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.313; its P/E ratio is -0.42; Harpoon Therapeutics is scheduled to report earnings on November 9, 2022, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 8.30M$ 5.91M$ 4.33M$ 4.48M$ 5.84M
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -17.41M$ -20.31M$ -21.54M$ -16.68M$ -16.77M
EBITDA$ -16.86M$ -19.71M$ -20.98M$ -16.14M$ -16.22M
Net Income Common Stockholders$ -17.35M$ -20.32M$ -21.55M$ -16.68M$ -16.76M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 90.15M$ 112.47M$ 126.03M$ 135.10M$ 151.39M
Total Assets$ 108.95M$ 132.45M$ 155.45M$ 174.67M$ 196.18M
Total Debt$ 10.83M$ 11.46M$ 12.02M$ 12.51M$ 12.99M
Net Debt$ -79.32M$ -101.01M$ -114.01M$ -122.59M$ -138.40M
Total Liabilities$ 82.31M$ 91.06M$ 97.38M$ 97.70M$ 105.25M
Stockholders Equity$ 26.64M$ 41.38M$ 53.84M$ 58.07M$ 60.74M
Cash Flow
Free Cash Flow$ -21.66M$ -25.24M$ -16.89M$ -20.68M$ -66.57M
Operating Cash Flow$ -21.60M$ -25.24M$ -16.83M$ -20.68M$ -66.57M
Investing Cash Flow$ 39.38M$ 30.46M$ 18.69M$ -14.12M$ 69.69M
Financing Cash Flow$ 52.00K$ 830.00K$ 47.00K$ 380.00K$ 2.95M
Currency in USD

Harpoon Therapeutics Earnings and Revenue History

Harpoon Therapeutics Debt to Assets

Harpoon Therapeutics Cash Flow

Harpoon Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis